← Back to Search

Local Anesthetic

bupivacaine for Labor Pain

N/A
Waitlist Available
Research Sponsored by Mark Kosanovich
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
adult pregnant women to age 45 with scheduled cesarean sections at Mercy Hospital and Medical Center
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post 120 minutes after arrival in the recovery room
Awards & highlights

Summary

This research will explore the question of whether preincisional skin infiltration with bupivacaine 0.25% decreases postoperative pain after Cesarean delivery.

Eligible Conditions
  • Labor Pain

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~120 minutes after arrival in the recovery room
This trial's timeline: 3 weeks for screening, Varies for treatment, and 120 minutes after arrival in the recovery room for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Final score on the visual analogous scale
Secondary study objectives
Analgesics

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: bupivacaineExperimental Treatment1 Intervention
Intervention
Group II: PlaceboPlacebo Group1 Intervention
Control
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Bupivacaine
FDA approved

Find a Location

Who is running the clinical trial?

Mark KosanovichLead Sponsor
Rohitkumar Vasa, MDStudy ChairIRB Chair
~13 spots leftby Sep 2025